Article
NOS3 and CTH gene mutations as new molecular markers for detection of lung adenocarcinoma.
PeerJ - 1 Jan 2023
Abdullah Ramadhan Iman, Rahman Sulaiman Luqman, Salihi Abbas
Abstract excerpt
Gene mutations can contribute to lung adenocarcinoma (LUAD) development, metastasis, and therapy. This study aims to identify mutations in the endothelial nitric oxide synthase (eNOS or NOS3) and cystathionine γ-lyase (CSE or CTH) genes that are connected to LUAD symptoms. Two gene polymorphisms were identified using Sanger sequencing in 31 LUAD patients' formalin-fixed paraffin-embedded (FFPE) tissues. Epidermal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
